Lives lost and disease burden related to antimicrobial resistance in the Americas can no longer be ignored

  02 October 2023

In this issue of The Lancet Regional Health—Americas, a Global Burden of Disease study led by the Antimicrobial Resistance Collaborators, provides the most comprehensive country-specific estimates of morbidity, mortality, and disability-adjusted life years (DALYs) attributable to and associated with AMR in the Americas to date. The authors estimate the burden of AMR in 35 American countries building on recent global approximations by Murray et al.  Two scenarios are presented: a lower-bound counterfactual, where resistant infections are replaced by susceptible infections (attributable to AMR), and an upper-bound scenario, where resistant infections would not occur (associated with AMR).

The results offer a staggering insight into the alarming magnitude of the problem in the region.

Author(s): Eduardo A. Undurraga et al
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed